2.9900
-0.0100
(-0.33%)
At close: January 10 at 5:36:22 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
73,398.0000
53,876.0000
29,146.0000
Total Liabilities Net Minority Interest
24,917.0000
15,410.0000
1,264.0000
Total Equity Gross Minority Interest
48,481.0000
38,466.0000
27,882.0000
Total Capitalization
48,481.0000
38,466.0000
27,882.0000
Common Stock Equity
48,481.0000
38,466.0000
27,882.0000
Net Tangible Assets
-4,084.0000
-9,422.0000
2,879.0000
Working Capital
9,314.0000
2,010.0000
2,056.0000
Invested Capital
48,481.0000
38,466.0000
27,882.0000
Tangible Book Value
-4,084.0000
-9,422.0000
2,879.0000
Share Issued
24,795.4770
24,795.4770
24,795.4770
Ordinary Shares Number
24,795.4770
24,795.4770
24,795.4770
12/31/2021 - 10/3/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NWRN.SW Newron Pharmaceuticals S.p.A.
8.88
+1.72%
ACHL Achilles Therapeutics plc
1.1850
-0.42%
OKUR OnKure Therapeutics, Inc.
7.43
-4.87%
GRTX Galera Therapeutics, Inc.
0.0480
-5.88%
OVID Ovid Therapeutics Inc.
0.8207
-9.80%
RLF.SW Relief Therapeutics Holding SA
3.8500
-1.53%
KZR Kezar Life Sciences, Inc.
6.51
-1.06%
VLA.PA Valneva SE
2.2160
+4.73%
BOLT Bolt Biotherapeutics, Inc.
0.5387
-4.69%
LSTA Lisata Therapeutics, Inc.
3.7300
-1.84%